Search

everythinglearnresearchcommunity

for

Search:↓

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Clascoterone cream could be used for other skin conditions affected by hormones.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Clascoterone 1% cream is a promising new treatment for acne.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Hormonal implants have many side effects that often outweigh their benefits.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

Leuprolide may better manage cholesterol and blood pressure in PCOS than spironolactone.

PrEP implants are promising for HIV prevention if the number of implants needed is minimized.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

The risks of testosterone implants in women outweigh the benefits.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Nanostructured lipid carriers can effectively deliver spironolactone to hair follicles for treating hair loss.

Norplant implants lower some androgen levels but don't significantly change sexual function.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.